Solvay Cilansetron NDA Filing Will Feature "Appropriate Use Plan" For Irritable Bowel Syndrome Drug

Proposed risk management plan for Lotronex cousin will likely include "novel educational approach" for physicians and patients, Solvay said. Company plans to file NDA for treatment of diarrhea-predominant IBS in men and women in the second quarter.